USE OF MICRONEEDLES FOR SMALL MOLECULE METABOLITE REPORTER DELIVERY
Systems that can include a microneedle array and a small molecule metabolic reporter are disclosed. The systems can be used to penetrate the epidermis and monitor the change in concentration of one or more metabolite or analyte.
1 . A system for delivering at least one small molecule metabolic reporter (SMMR) into the human epidermis, comprising:
at least one SMMR; and
a microneedle array;
wherein said microneedle array penetrates said epidermis to facilitate delivery of said SMMR.
2 . The system of claim 1 , wherein the at least one SMMR comprises a compound of Formula (I):
wherein D is a heteroatom;
R 1 is selected from the group consisting of H, OH, CH 3 , CF 3 , M, an amino group, and a substituted amino group;
R 2 is selected from the group consisting of H, CH 3 , and M;
R 3 , R 4 , and R 5 are each independently selected from the group consisting of H, OH, alkoxy, M, an amino group, and a substituted amino group;
M is selected from the group consisting of Formula (II) and Formula (III):
L, when present, is an amino-containing linking moiety; and
at least one boronic acid moiety is present.
3 . An in vivo method for delivering at least one SMMR into the human epidermis, comprising:
contacting said SMMR with a microneedle array, and;
penetrating said epidermis with said array to a depth of about 10 μm, wherein said depth corresponds with the bottom of the dead stratum corneum layer, to about 175 μm, wherein said depth corresponds with the top of the dermal layer.
4 . The method of claim 3 , wherein the at least one SMMR comprises a compound of Formula (I):
wherein D is a heteroatom;
R 1 is selected from the group consisting of H, OH, CH 3 , CF 3 , M, an amino group, and a substituted amino group;
R 2 is selected from the group consisting of H, CH 3 , and M;
R 3 , R 4 , and R 5 are each independently selected from the group consisting of H, OH, alkoxy, M, an amino group, and a substituted amino group;
M is selected from the group consisting of Formula (II) and Formula (III):
L, when present, is an amino-containing linking moiety; and
at least one boronic acid moiety is present.
5 . The method of claim 3 , wherein said microneedle array comprises solid microneedles.
6 . The method of claim 5 , wherein said contact between at least one SMMR and microneedle array comprises lining the array of microneedles with at least one SMMR.
7 . The method of claim 5 , wherein said contact between at least one SMMR and microneedle array comprises an array of microneedles with SMMR tips.
8 . The method of claim 3 , wherein said microneedle array comprises hollow microneedles.
9 . The method of claim 8 , wherein said contact between at least one SMMR and microneedle array comprises filling said hollow microneedles with at least one SMMR.
10 . The method of claim 9 , further comprising the step of injecting said at least one SMMR into the epidermis with a syringe.
11 . The method of claim 3 , wherein said contact between at least one SMMR and microneedle array comprises contacting said array with at least one SMMR applied directly to skin.
12 . An in vivo method for monitoring the concentration of one or more metabolite or analyte, the method comprising:
contacting at least one SMMR with a microneedle array;
penetrating the human epidermis with said microneedles to a depth of about 10 μm, wherein said depth corresponds with the bottom of the dead stratum corneum layer, to about 175 μm, wherein said depth corresponds with the top of the dermal layer; and
monitoring a change in the concentration of the one or more metabolite or analyte in a metabolic pathway by detecting changes in the at least one SMMR at one or more time points using an optical reader.
13 . The method of claim 12 , wherein said one or more metabolite or analyte comprises glucose.
14 . The method of claim 13 , wherein the at least one SMMR comprises a compound of Formula (I):
wherein D is a heteroatom;
R 1 is selected from the group consisting of H, OH, CH 3 , CF 3 , M, an amino group, and a substituted amino group;
R 2 is selected from the group consisting of H, CH 3 , and M;
R 3 , R 4 , and R 5 are each independently selected from the group consisting of H, OH, alkoxy, M, an amino group, and a substituted amino group;
M is selected from the group consisting of Formula (II) and Formula (III):
L, when present, is an amino-containing linking moiety; and
at least one boronic acid moiety is present.